These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38371552)

  • 1. Dose-Adjusted FRAX Score in Pemphigus Vulgaris Treatment.
    Guzmán-Herrera S; Morales-Sánchez MA; Peralta-Pedrero ML; de Peña-Ortiz J; Cruz FJS
    Indian J Dermatol; 2023; 68(6):698-700. PubMed ID: 38371552
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.
    Olszewska M; Kolacinska-Strasz Z; Sulej J; Labecka H; Cwikla J; Natorska U; Blaszczyk M
    Am J Clin Dermatol; 2007; 8(2):85-92. PubMed ID: 17428113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prolonged complete clinical remission in patients with severe pemphigus vulgaris after cycles of intravenous cyclophosphamide].
    España Alonso A; Panizo C; Fernández S; Marquina M; Pretel M; Aguado L; Sánchez-Ibarrola A
    Actas Dermosifiliogr; 2009 Mar; 100(2):113-20. PubMed ID: 19445875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids.
    Werth VP
    Arch Dermatol; 1996 Dec; 132(12):1435-9. PubMed ID: 8961871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophageal involvement of pemphigus vulgaris associated with upper gastrointestinal bleeding.
    Chang S; Park SJ; Kim SW; Jin MN; Lee JH; Kim HJ; Hong SP; Kim TI
    Clin Endosc; 2014 Sep; 47(5):452-4. PubMed ID: 25325007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris.
    Werth VP; Joly P; Mimouni D; Maverakis E; Caux F; Lehane P; Gearhart L; Kapre A; Pordeli P; Chen DM;
    N Engl J Med; 2021 Jun; 384(24):2295-2305. PubMed ID: 34097368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pemphigus vulgaris with psoriasis vulgaris successfully treated with methotrexate and low-dose methylprednisolone.
    Zheng J; Liu N; Wang Y; Chen F; Ding Y
    Dermatol Ther; 2020 Jan; 33(1):e13165. PubMed ID: 31705774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intralesional Rituximab in the Treatment of Refractory Oral Pemphigus Vulgaris.
    Vinay K; Kanwar AJ; Mittal A; Dogra S; Minz RW; Hashimoto T
    JAMA Dermatol; 2015 Aug; 151(8):878-82. PubMed ID: 25536513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolate mofetil and enteric-coated mycophenolate sodium in the treatment of pemphigus vulgaris and pemphigus foliaceus.
    Doukaki S; Platamone A; Alaimo R; Bongiorno MR
    J Dermatolog Treat; 2015 Feb; 26(1):67-72. PubMed ID: 24521072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of pemphigus vulgaris in the Northeast China: a 10-year retrospective study.
    Zhu X; Pan J; Yu Z; Wang Y; Cai L; Zheng S
    J Dermatol; 2014 Jan; 41(1):70-5. PubMed ID: 24354355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Combined Use of Dupilumab for Treatment of Aggressive Refractory Pemphigus Vulgaris Complicated With Pulmonary Tuberculosis: A Case Report and the RNA-seq Analysis.
    Chen S; Zhan S; Hua C; Tang Y; Cheng H
    Front Immunol; 2022; 13():825796. PubMed ID: 35222408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of pemphigus vulgaris with pulse intravenous cyclophosphamide.
    Pandya AG; Sontheimer RD
    Arch Dermatol; 1992 Dec; 128(12):1626-30. PubMed ID: 1456758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of three different dose regimens of methylprednisolone as initial therapy for pemphigus vulgaris of moderate severity: A single-center retrospective study from Turkey.
    Polat Ekinci A; Kiliç Sayar S; Babuna Kobaner G; Küçükoğlu R
    Australas J Dermatol; 2021 May; 62(2):199-205. PubMed ID: 33660847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study.
    Langan SM; Smeeth L; Hubbard R; Fleming KM; Smith CJ; West J
    BMJ; 2008 Jul; 337(7662):a180. PubMed ID: 18614511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Rituximab in the Treatment of Pemphigus Vulgaris: Patient Selection and Acceptability.
    Ciolfi C; Sernicola A; Alaibac M
    Patient Prefer Adherence; 2022; 16():3035-3043. PubMed ID: 36387051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged treatment with rituximab in patients with refractory pemphigus vulgaris.
    Barrera MV; Mendiola MV; Bosch RJ; Herrera E
    J Dermatolog Treat; 2007; 18(5):312-4. PubMed ID: 17852643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultra-low dose rituximab for refractory pemghigus vulgaris: a pilot study.
    Russo I; Miotto S; Saponeri A; Alaibac M
    Expert Opin Biol Ther; 2020 Jun; 20(6):673-678. PubMed ID: 32027810
    [No Abstract]   [Full Text] [Related]  

  • 18. Pemphigus vulgaris: an evidence-based treatment update.
    Zhao CY; Murrell DF
    Drugs; 2015 Feb; 75(3):271-84. PubMed ID: 25655250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the commitment index of skin and mucous membranes in pemphigus vulgaris for the clinical evaluation of patients with pemphigus vulgaris.
    Souza SR; Azulay-Abulafia L; Nascimento LV
    An Bras Dermatol; 2011; 86(2):284-91. PubMed ID: 21603812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Utility Analysis of Rituximab vs Mycophenolate Mofetil for the Treatment of Pemphigus Vulgaris.
    Chen MKY; Vissapragada R; Bulamu N; Gupta M; Werth V; Sebaratnam DF
    JAMA Dermatol; 2022 Sep; 158(9):1013-1021. PubMed ID: 35895045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.